{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:51:51Z","timestamp":1787032311915,"version":"build-2736575974"},"reference-count":52,"publisher":"The Pediatric Pharmacy Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>This study describes our experience with a clonidine transition protocol to prevent dexmedetomidine (DEX) withdrawal in critically ill pediatric patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Retrospective review of electronic medical records of patients in the pediatric intensive care unit of a single tertiary children's hospital. All patients up to 19 years of age, who received concomitant DEX infusion and enteral clonidine between June 1, 2016, and May 31, 2018, were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Two of 24 encounters had DEX restarted for withdrawal (8.3%). Five of 14 encounters who were transitioned to clonidine 2 mcg\/kg every 6 hours required an increased dose, and 1 of 10 encounters transitioned to clonidine 4 mcg\/kg every 6 hours required an increased dose (36% vs 10%, p = 0.21). For encounters with clonidine dose increases, 5 of 6 had improvements in Withdrawal Assessment Tool-1 (WAT-1) scores. Of these 5 encounters, 4 had decreasing or stable opioid and sedative requirements and 1 was transitioned to methadone. No encounters required discontinuation of clonidine owing to adverse events. Two of 24 encounters met our safety endpoint. One received a fluid bolus during the clonidine transition with no change in clonidine dosing, while the other had clonidine dose decreased for asymptomatic bradycardia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The 24 encounters in our retrospective study add to the limited literature available to describe dosing, initiation time, and duration of clonidine to prevent withdrawal from DEX in critically ill pediatric patients. Further research is needed to clarify the optimal dosing and duration of clonidine to prevent DEX withdrawal in pediatric patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5863\/1551-6776-25.4.278","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T16:51:05Z","timestamp":1589820665000},"page":"278-287","source":"Crossref","is-referenced-by-count":2,"title":["The Impact of a Clonidine Transition Protocol on Dexmedetomidine Withdrawal in Critically Ill Pediatric Patients"],"prefix":"10.5863","volume":"25","author":[{"given":"JiTong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bagwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"1","key":"i1551-6776-25-4-278-b1","series-title":"Pharmacotherapy","first-page":"51","article-title":"Use of dexmedetomidine in the pediatric intensive care unit","volume":"28","year":"2008","unstructured":"Buck\n              ML\n            , WilsonDF.\n          Use of dexmedetomidine in the pediatric intensive care unit. Pharmacotherapy. 2008;28(1):51\u201357."},{"issue":"2","key":"i1551-6776-25-4-278-b2","series-title":"Pediatr Crit Care Med","first-page":"115","article-title":"Dexmedetomidine: applications in pediatric critical are and pediatric anesthesiology","volume":"8","year":"2007","unstructured":"Tobias\n              JD.\n            \n          \n          Dexmedetomidine: applications in pediatric critical are and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8(2):115\u2013131."},{"issue":"12","key":"i1551-6776-25-4-278-b3","series-title":"Pediatr Crit Care Med","first-page":"1131","article-title":"Randomized evaluation of sedation titration for respiratory failure study investigators: dexmedetomidine use in critically ill children with acute respiratory failure","volume":"17","year":"2016","unstructured":"Grant\n              MJ\n            , SchneiderJB, AsaroLA, \n          et al. Randomized evaluation of sedation titration for respiratory failure study investigators: dexmedetomidine use in critically ill children with acute respiratory failure. Pediatr Crit Care Med. 2016;17(12):1131\u20131141."},{"issue":"2","key":"i1551-6776-25-4-278-b4","series-title":"Pediatr Crit Care Med","first-page":"66","article-title":"Efficacy of \u03b12-agonists for sedation in pediatric critical care: a systematic review","volume":"17","year":"2016","unstructured":"Hayden\n              JC\n            , BreatnachC, DohertyDR, \n          et al. Efficacy of \u03b12-agonists for sedation in pediatric critical care: a systematic review. Pediatr Crit Care Med. 2016;17(2):66\u201375."},{"issue":"1","key":"i1551-6776-25-4-278-b5","series-title":"Pediatr Crit Care Med","first-page":"39","article-title":"Dexmedetomidine sedation in children after cardiac surgery","volume":"11","year":"2010","unstructured":"Hosokawa\n              K\n            , ShimeN, KatoY, \n          et al. Dexmedetomidine sedation in children after cardiac surgery. Pediatr Crit Care Med. 2010;11(1):39\u201343."},{"issue":"3","key":"i1551-6776-25-4-278-b6","series-title":"Ann Pediatr Cardiol","first-page":"167","article-title":"Efficacy of dexmedetomidine for the control of junctional ectopic tachycardia after repair of tetralogy of Fallot","volume":"7","year":"2014","unstructured":"Rajput\n              RS\n            , DasS, MakhijaN, AiranB.\n          Efficacy of dexmedetomidine for the control of junctional ectopic tachycardia after repair of tetralogy of Fallot. Ann Pediatr Cardiol. 2014;7(3):167\u2013172."},{"issue":"3","key":"i1551-6776-25-4-278-b7","series-title":"Paediatr Anaesth","first-page":"239","article-title":"Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis","volume":"26","year":"2015","unstructured":"Pan\n              W\n            , WandY, LinL, \n          et al. Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis. Paediatr Anaesth. 2015;26(3):239\u2013248."},{"issue":"5","key":"i1551-6776-25-4-278-b8","series-title":"Intensive Care Med","first-page":"836","article-title":"Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease","volume":"36","year":"2010","unstructured":"Chrysostomou\n              C\n            , KomaruluR, LichtensteinS, \n          et al. Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med. 2010;36(5):836\u2013842."},{"issue":"2","key":"i1551-6776-25-4-278-b9","series-title":"Intensive Care Med","first-page":"300","article-title":"Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease","volume":"38","year":"2012","unstructured":"Burbano\n              NH\n            , OteroAV, BerryDE, \n          et al. Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease. Intensive Care Med. 2012;38(2):300\u2013307."},{"issue":"1","key":"i1551-6776-25-4-278-b10","series-title":"Hum Exp Toxicol","first-page":"107","article-title":"Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: report of cases and review of the literature","volume":"32","year":"2013","unstructured":"Kukoyi\n              A\n            , CokerS, LewisL, \n          et al. Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: report of cases and review of the literature. Hum Exp Toxicol. 2013;32(1):107\u2013110."},{"issue":"1","key":"i1551-6776-25-4-278-b11","series-title":"J Pediatr Pharmacol Ther","first-page":"38","article-title":"Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child","volume":"15","year":"2010","unstructured":"Miller\n              JL\n            , AllenC, JohnsonPN.\n          Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child. J Pediatr Pharmacol Ther. 2010;15(1):38\u201342."},{"issue":"6","key":"i1551-6776-25-4-278-b12","series-title":"J Pediatr Pharmacol Ther","first-page":"453","article-title":"Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children","volume":"22","year":"2017","unstructured":"Haenecour\n              AS\n            , SetoW, UrbainCM, \n          et al. Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children. J Pediatr Pharmacol Ther. 2017;22(6):453\u2013460."},{"issue":"8","key":"i1551-6776-25-4-278-b13","series-title":"Pediatr Crit Care Med","first-page":"706","article-title":"Long-term dexmedetomidine use and safety profile among critically ill children and neonates","volume":"15","year":"2014","unstructured":"Whalen\n              LD\n            , Di GennaroJl, IrbyGA, \n          et al. Long-term dexmedetomidine use and safety profile among critically ill children and neonates. Pediatr Crit Care Med. 2014;15(8):706\u2013714."},{"issue":"5","key":"i1551-6776-25-4-278-b14","series-title":"Am J Crit Care","first-page":"364","article-title":"Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation","volume":"7","year":"1998","unstructured":"Franck\n              LS\n            , VilardiJ, DurandD, \n          et al. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Crit Care. 1998;7(5):364\u2013369."},{"issue":"5","key":"i1551-6776-25-4-278-b15","series-title":"Pediatrics","first-page":"1208","article-title":"Tolerance and withdrawal from prolonged opioid use in critically ill children","volume":"125","year":"2010","unstructured":"Anand\n              KJ\n            , WillsonDF, BergerJ, \n          et al. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics. 2010;125(5):1208\u20131225."},{"key":"i1551-6776-25-4-278-b16","series-title":"Intensive Crit Care Nurs","first-page":"71","article-title":"Parent's experiences of their child's withdrawal syndrome: a driver for reciprocal nurse-parent partnership in withdrawal assessment","volume":"50","year":"2019","unstructured":"Craske\n              J\n            , CarterB, JarmanI, \n          et al. Parent's experiences of their child's withdrawal syndrome: a driver for reciprocal nurse-parent partnership in withdrawal assessment. Intensive Crit Care Nurs. 2019;50:71\u201378."},{"issue":"1","key":"i1551-6776-25-4-278-b17","series-title":"J Pediatr Pharmacol Ther","first-page":"4","article-title":"Dexmedetomidine: are there going to be issues with prolonged administration?","volume":"15","year":"2010","unstructured":"Tobias\n              JD.\n            \n          \n          Dexmedetomidine: are there going to be issues with prolonged administration?\n          J Pediatr Pharmacol Ther. 2010;15(1):4\u20139."},{"issue":"6","key":"i1551-6776-25-4-278-b18","series-title":"Pediatr Crit Care Med","first-page":"696","article-title":"Dexmedetomidine: should it be standard after pediatric cardiac surgery?","volume":"13","year":"2012","unstructured":"Chrysostomou\n              C.\n            \n          \n          Dexmedetomidine: should it be standard after pediatric cardiac surgery?\n          Pediatr Crit Care Med. 2012;13(6):696\u2013697."},{"issue":"4","key":"i1551-6776-25-4-278-b19","series-title":"Pediatr Crit Care Med","first-page":"287","article-title":"Dexmedetomidine as single continuous sedative during noninvasive ventilation: typical usage, hemodynamic effects, and withdrawal","volume":"19","year":"2018","unstructured":"Shutes\n              BL\n            , GeeSW, SargelCL, \n          et al. Dexmedetomidine as single continuous sedative during noninvasive ventilation: typical usage, hemodynamic effects, and withdrawal. Pediatr Crit Care Med. 2018;19(4):287\u2013297."},{"issue":"1","key":"i1551-6776-25-4-278-b20","series-title":"J Pediatr Pharmacol Ther","first-page":"45","article-title":"Effects of clonidine on withdrawal from long-term dexmedetomidine in pediatric patients","volume":"20","year":"2015","unstructured":"Lardieri\n              AB\n            , FuscoNM, SimoneS, \n          et al. Effects of clonidine on withdrawal from long-term dexmedetomidine in pediatric patients. J Pediatr Pharmacol Ther. 2015;20(1):45\u201353."},{"issue":"5","key":"i1551-6776-25-4-278-b21","series-title":"Pediatrics","first-page":"849","article-title":"Clonidine as an adjunct to opioids for neonatal abstinence syndrome: a randomized controlled trial","volume":"123","year":"2009","unstructured":"Agthe\n              AG\n            , KimGR, MathiasKB, \n          et al. Clonidine as an adjunct to opioids for neonatal abstinence syndrome: a randomized controlled trial. Pediatrics. 2009;123(5):849\u2013856."},{"issue":"2","key":"i1551-6776-25-4-278-b22","series-title":"Pediatrics","first-page":"383","article-title":"Morphine versus clonidine for neonatal abstinence syndrome","volume":"135","year":"2015","unstructured":"Bada\n              HS\n            , SithisarnT, GibsonJ, \n          et al. Morphine versus clonidine for neonatal abstinence syndrome. Pediatrics. 2015;135(2):383\u2013391."},{"issue":"4","key":"i1551-6776-25-4-278-b23","series-title":"J Med Toxicol","first-page":"369","article-title":"Is it prime rime for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?","volume":"10","year":"2014","unstructured":"Albertson\n              TE\n            , ChenowethJ, FordJ, \n          et al. Is it prime rime for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?J Med Toxicol. 2014;10(4):369\u2013381."},{"issue":"6","key":"i1551-6776-25-4-278-b24","series-title":"Pediatr Crit Care Med","first-page":"521","article-title":"Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs","volume":"5","year":"2004","unstructured":"Twite\n              MD\n            , RashidA, ZukJ, \n          et al. Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs. Pediatr Crit Care Med. 2004;5(6):521\u2013532."},{"issue":"8","key":"i1551-6776-25-4-278-b25","series-title":"Intensive Care Med","first-page":"1125","article-title":"Consensus guidelines on sedation and analgesia in critically ill children","volume":"32","year":"2006","unstructured":"Playfor\n              S\n            , JenkinsI, BoylesC, \n          et al. Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med. 2006;32(8):1125\u20131136."},{"issue":"7","key":"i1551-6776-25-4-278-b26","series-title":"Paediatr Anaesth","first-page":"675","article-title":"Current United Kingdom sedation practice in pediatric intensive care","volume":"17","year":"2007","unstructured":"Jenkins, IA, PlayforS, BevanC, \n          et al. Current United Kingdom sedation practice in pediatric intensive care. Paediatr Anaesth. 2007;17(7):675\u2013683."},{"issue":"8","key":"i1551-6776-25-4-278-b27","series-title":"Intensive Care Med","first-page":"1625","article-title":"Use of oral clonidine for sedation in ventilated paediatric intensive care patients","volume":"30","year":"2004","unstructured":"Arenas-L\u00f3pez\n              S\n            , RiphagenS, TibbySM, \n          et al. Use of oral clonidine for sedation in ventilated paediatric intensive care patients. Intensive Care Med. 2004;30(8):1625\u20131629."},{"issue":"6","key":"i1551-6776-25-4-278-b28","series-title":"Br J Anaesth","first-page":"964","article-title":"Enteral absorption and haemodynamic response of clonidine in infants post-cardiac surgery","volume":"113","year":"2014","unstructured":"Arenas-L\u00f3pez\n              S\n            , MullaH, MannaS, \n          et al. Enteral absorption and haemodynamic response of clonidine in infants post-cardiac surgery. Br J Anaesth. 2014;113(6):964\u2013969."},{"issue":"5","key":"i1551-6776-25-4-278-b29","series-title":"J Crit Care","first-page":"758","article-title":"Clonidine in the sedation of mechanically ventilated children: a pilot randomized trial","volume":"29","year":"2014","unstructured":"Duffett\n              M\n            , ChoongK, FosterJ, \n          et al. Clonidine in the sedation of mechanically ventilated children: a pilot randomized trial. J Crit Care. 2014;29(5):758\u2013763."},{"issue":"3","key":"i1551-6776-25-4-278-b30","series-title":"Paediatr Anaesth","first-page":"217","article-title":"Intravenous clonidine infusion in infants after cardiovascular surgery","volume":"18","year":"2008","unstructured":"Pohl-Schickinger\n              A\n            , LemmerJ, H\u00fcblerM, \n          et al. Intravenous clonidine infusion in infants after cardiovascular surgery. Paediatr Anaesth. 2008;18(3):217\u2013222."},{"issue":"6","key":"i1551-6776-25-4-278-b31","series-title":"Br J Anaesth","first-page":"794","article-title":"Intravenous clonidine infusion in critically ill children: dose-dependent sedative effects and cardiovascular stability","volume":"84","year":"2000","unstructured":"Ambrose\n              C\n            , SaleS, HowellsR, \n          et al. Intravenous clonidine infusion in critically ill children: dose-dependent sedative effects and cardiovascular stability. Br J Anaesth. 2000;84(6):794\u2013796."},{"issue":"71","key":"i1551-6776-25-4-278-b32","series-title":"Health Technol Assess","first-page":"1","article-title":"Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy, and Equivalence in Paediatric intensive care Sedation) study","volume":"18","year":"2014","unstructured":"Wolf\n              A\n            , McKayA, SpowartC, \n          et al. Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy, and Equivalence in Paediatric intensive care Sedation) study. Health Technol Assess. 2014;18(71):1\u2013212."},{"issue":"6","key":"i1551-6776-25-4-278-b33","series-title":"Pediatr Crit Care Med","first-page":"511","article-title":"Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trial","volume":"15","year":"2014","unstructured":"H\u00fcnseler\n              C\n            , BallingG, R\u00f6hligC, \n          et al. Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trial. Pediatr Crit Care Med. 2014;15(6):511\u2013522."},{"key":"i1551-6776-25-4-278-b34","series-title":"Clonidine [package insert]","year":"2011","unstructured":"Clonidine [package insert]. Ridgefield, CT. Boehringer Ingelheim Pharmaceuticals Inc; 2011."},{"key":"i1551-6776-25-4-278-b35","series-title":"Active ingredient: clonidine hydrochloride. RED BOOK Online. Micromedex Healthcare Series","year":"2015","unstructured":"Active ingredient: clonidine hydrochloride. RED BOOK Online. Micromedex Healthcare Series. Armonk, NY: IBM Watson Health; 2015. URL. Accessed September 3, 2019."},{"key":"i1551-6776-25-4-278-b36","series-title":"Active ingredient: dexmedetomidine hydrochloride. RED BOOK Online. Micromedex Healthcare Series","year":"2015","unstructured":"Active ingredient: dexmedetomidine hydrochloride. RED BOOK Online. Micromedex Healthcare Series. Armonk, NY: IBM Watson Health; 2015. URL. Accessed September 3, 2019."},{"issue":"1","key":"i1551-6776-25-4-278-b37","series-title":"J Pediatr Pharmacol Ther","first-page":"16","article-title":"Survey of the current use of dexmedetomidine and management of withdrawal symptoms in critically ill children","volume":"24","year":"2019","unstructured":"Thompson\n              ZR\n            , GardnerBM, AutryEB, \n          et al. Survey of the current use of dexmedetomidine and management of withdrawal symptoms in critically ill children. J Pediatr Pharmacol Ther. 2019;24(1):16\u201321."},{"issue":"2","key":"i1551-6776-25-4-278-b38","series-title":"J Biomed Inform","first-page":"377","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","unstructured":"Harris\n              PA\n            , TaylorR, ThielkeR, \n          et al. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u2013381."},{"key":"i1551-6776-25-4-278-b39","series-title":"J Biomed Inform","first-page":"103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","year":"2019","unstructured":"Harris\n              PA\n            , TaylorR, MinorBL, \n          et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi: 10.1016\/j.jbi.2019.103208."},{"issue":"6","key":"i1551-6776-25-4-278-b40","series-title":"Intensive Crit Care Nurs","first-page":"344","article-title":"Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients","volume":"20","year":"2004","unstructured":"Franck\n              LS\n            , NaughtonI, WinterI.\n          Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive Crit Care Nurs. 2004;20(6):344\u2013351."},{"issue":"3","key":"i1551-6776-25-4-278-b41","series-title":"Intensive Crit Care Nurs","first-page":"179","article-title":"A prospective study of adverse reactions to weaning opioids and benzodiazepines among critically ill children","volume":"21","year":"2005","unstructured":"Ducharme\n              C\n            , CarnevaleFA, ClermontMS, \n          et al. A prospective study of adverse reactions to weaning opioids and benzodiazepines among critically ill children. Intensive Crit Care Nurs. 2005;21(3):179\u2013186."},{"issue":"4","key":"i1551-6776-25-4-278-b42","series-title":"Anesth Analg","first-page":"1045","article-title":"A prospective evaluation of opioid weaning in opioid dependent pediatric critical care patients","volume":"102","year":"2006","unstructured":"Berens\n              RJ\n            , MeyerMT, MikhailovTA, \n          et al. A prospective evaluation of opioid weaning in opioid dependent pediatric critical care patients. Anesth Analg. 2006;102(4):1045\u20131050."},{"issue":"3","key":"i1551-6776-25-4-278-b43","series-title":"Pharmacotherapy","first-page":"251","article-title":"Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study","volume":"35","year":"2015","unstructured":"Gagnon\n              DJ\n            , RikerRR, GlisicEK, \n          et al. Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study. Pharmacotherapy. 2015;35(3):251\u2013259."},{"issue":"10","key":"i1551-6776-25-4-278-b44","series-title":"Paediatr Anaesth","first-page":"924","article-title":"Clonidine disposition in children; a population analysis","volume":"17","year":"2007","unstructured":"Potts\n              AL\n            , LarssonP, EksborgS, \n          et al. Clonidine disposition in children; a population analysis. Paediatr Anaesth. 2007;17(10):924\u2013933."},{"issue":"12","key":"i1551-6776-25-4-278-b45","series-title":"Paediatr Anaesth","first-page":"1143","article-title":"Premedication in children: a comparison of oral midazolam and oral clonidine","volume":"17","year":"2007","unstructured":"Almenrader\n              N\n            , PassarielloM, CoccettiB, \n          et al. Premedication in children: a comparison of oral midazolam and oral clonidine. Paediatr Anaesth. 2007;17(12):1143\u20131149."},{"issue":"6","key":"i1551-6776-25-4-278-b46","series-title":"Pediatr Crit Care Med","first-page":"573","article-title":"The withdrawal assessment tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients","volume":"9","year":"2008","unstructured":"Franck\n              LS\n            , HarrisSK, SoetengaDJ, \n          et al. The withdrawal assessment tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients. Pediatr Crit Care Med. 2008;9(6):573\u2013580."},{"issue":"1","key":"i1551-6776-25-4-278-b47","series-title":"Pain","first-page":"142","article-title":"Validity and generalizability of the withdrawal assessment tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients","volume":"153","year":"2012","unstructured":"Franck\n              LS\n            , ScoppettuoloLA, WypijD, \n          et al. Validity and generalizability of the withdrawal assessment tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients. Pain. 2012;153(1):142\u2013148."},{"issue":"2","key":"i1551-6776-25-4-278-b48","series-title":"Pediatr Crit Care Med","first-page":"107","article-title":"State behavioral scale: a sedation assessment instrument for infants and young children supported on mechanical ventilation","volume":"7","year":"2006","unstructured":"Curley\n              MA\n            , HarrisSK, FraserKA, \n          et al. State behavioral scale: a sedation assessment instrument for infants and young children supported on mechanical ventilation. Pediatr Crit Care Med. 2006;7(2):107\u2013114."},{"issue":"5","key":"i1551-6776-25-4-278-b49","series-title":"J Clin Psychiatry","first-page":"7","article-title":"Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound","volume":"65","year":"2004","unstructured":"Chouinard\n              G.\n            \n          \n          Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry. 2004;65(5):7\u201312."},{"issue":"5","key":"i1551-6776-25-4-278-b50","series-title":"Clin J Pain","first-page":"286","article-title":"Clinical application of opioid equianalgesic data","volume":"19","year":"2003","unstructured":"Gammaitoni\n              AR\n            , FineP, AlvarezN, \n          et al. Clinical application of opioid equianalgesic data. Clin J Pain. 2003;19(5):286\u2013297."},{"key":"i1551-6776-25-4-278-b51","series-title":"Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing","year":"2009","unstructured":"McPherson\n              ML.\n            \n          \n          Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing. Bethesda, MD: American Society of Health-System Pharmacists; 2009."},{"issue":"13","key":"i1551-6776-25-4-278-b52","series-title":"Am J Health Syst Pharm","first-page":"1233","article-title":"Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients","volume":"68","year":"2011","unstructured":"Oschman\n              A\n            , MccabeT, KuhnRJ.\n          Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients. Am J Health Syst Pharm. 2011;68(13):1233\u20131238."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/4\/article-p278.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/25\/4\/278\/2564290\/1551-6776-25_4_278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/4\/article-p278.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/4\/article-p278.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T20:38:14Z","timestamp":1747341494000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/4\/article-p278.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":52,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-25.4.278","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}